816 related articles for article (PubMed ID: 11427792)
1. [Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].
Skowron F; Bérard F; Grézard P; Wolf F; Morel Y; Perrot H
Ann Dermatol Venereol; 2001 May; 128(5):600-4. PubMed ID: 11427792
[TBL] [Abstract][Full Text] [Related]
2. The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients.
Stuart KA; Busfield F; Jazwinska EC; Gibson P; Butterworth LA; Cooksley WG; Powell LW; Crawford DH
J Hepatol; 1998 Mar; 28(3):404-9. PubMed ID: 9551677
[TBL] [Abstract][Full Text] [Related]
3. HFE mutations and transferrin receptor polymorphism analysis in porphyria cutanea tarda: a prospective study of 36 cases from southern France.
Dereure O; Aguilar-Martinez P; Bessis D; Perney P; Vallat C; Guillot B; Blanc F; Guilhou JJ
Br J Dermatol; 2001 Mar; 144(3):533-9. PubMed ID: 11260010
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of hemochromatosis-related HFE C282Y/H63D gene mutations in patients on chronic dialysis.
Canavese C; Bergamo D; Barbieri S; Timbaldi M; Thea A; Martina G; Damiani D; Fenoglio R; Donati-Marella B; Priolo G
Clin Nephrol; 2002 Dec; 58(6):438-44. PubMed ID: 12508966
[TBL] [Abstract][Full Text] [Related]
5. Porphyria cutanea tarda in Brazilian patients: association with hemochromatosis C282Y mutation and hepatitis C virus infection.
Martinelli AL; Zago MA; Roselino AM; Filho AB; Villanova MG; Secaf M; Tavella MH; Ramalho LN; Zucoloto S; Franco RF
Am J Gastroenterol; 2000 Dec; 95(12):3516-21. PubMed ID: 11151887
[TBL] [Abstract][Full Text] [Related]
6. Association of porphyria cutanea tarda with hereditary hemochromatosis.
Mehrany K; Drage LA; Brandhagen DJ; Pittelkow MR
J Am Acad Dermatol; 2004 Aug; 51(2):205-11. PubMed ID: 15280838
[TBL] [Abstract][Full Text] [Related]
7. Precipitating factors of porphyria cutanea tarda in Brazil with emphasis on hemochromatosis gene (HFE) mutations. Study of 60 patients.
Vieira FM; Nakhle MC; Abrantes-Lemos CP; Cançado EL; Reis VM
An Bras Dermatol; 2013; 88(4):530-40. PubMed ID: 24068123
[TBL] [Abstract][Full Text] [Related]
8. Hemochromatosis (HFE) and transferrin receptor-1 (TFRC1) genes in sporadic porphyria cutanea tarda (sPCT).
Lamoril J; Andant C; Gouya L; Malonova E; Grandchamp B; Martásek P; Deybac JC; Puy H
Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):33-41. PubMed ID: 11929045
[TBL] [Abstract][Full Text] [Related]
9. C282Y and H63D mutation of the hemochromatosis gene in German porphyria cutanea tarda patients.
Tannapfel A; Stölzel U; Köstler E; Melz S; Richter M; Keim V; Schuppan D; Wittekind C
Virchows Arch; 2001 Jul; 439(1):1-5. PubMed ID: 11499833
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection.
Toll A; Celis R; Ozalla MD; Bruguera M; Herrero C; Ercilla MG
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1201-6. PubMed ID: 17062032
[TBL] [Abstract][Full Text] [Related]
11. Hemochromatosis (HFE) gene mutations and response to chloroquine in porphyria cutanea tarda.
Stölzel U; Köstler E; Schuppan D; Richter M; Wollina U; Doss MO; Wittekind C; Tannapfel A
Arch Dermatol; 2003 Mar; 139(3):309-13. PubMed ID: 12622622
[TBL] [Abstract][Full Text] [Related]
12. Porphyria cutanea tarda, C282Y, H63D and S65C HFE gene mutations and hepatitis C infection: a study from southern France.
Chiavérini C; Halimi G; Ouzan D; Halfon P; Ortonne JP; Lacour JP
Dermatology; 2003; 206(3):212-6. PubMed ID: 12673077
[TBL] [Abstract][Full Text] [Related]
13. [Are the hemochromatosis (HFE) gene mutation and hepatitis C virus (HCV) infection risk factors for porphyria cutanea tarda?].
Nagy Z; Kószó F; Pár A; Nagy A; Horányi M; Morvay M; Dobozy A; Mózsik G
Orv Hetil; 2000 Sep; 141(37):2031-4. PubMed ID: 11037612
[TBL] [Abstract][Full Text] [Related]
14. Significance of H63D homozygosity in a Basque population with hemochromatosis.
Castiella A; Zapata E; de Juan MD; Otazua P; Fernandez J; Zubiaurre L; Arriola JA;
J Gastroenterol Hepatol; 2010 Jul; 25(7):1295-8. PubMed ID: 20594259
[TBL] [Abstract][Full Text] [Related]
15. Hemochromatosis (HFE) gene mutations and hepatitis C virus infection as risk factors for porphyria cutanea tarda in Hungarian patients.
Nagy Z; Kószó F; Pár A; Emri G; Horkay I; Horányi M; Karádi O; Rumi G; Morvay M; Varga V; Dobozy A; Mózsik G
Liver Int; 2004 Feb; 24(1):16-20. PubMed ID: 15101996
[TBL] [Abstract][Full Text] [Related]
16. Iron-overload and genotypic expression of HFE mutations H63D/C282Y and transferrin receptor Hin6I and BanI polymorphism in german patients with hereditary haemochromatosis.
Gottschalk R; Seidl C; Schilling S; Braner A; Seifried E; Hoelzer D; Kaltwasser JP
Eur J Immunogenet; 2000 Jun; 27(3):129-34. PubMed ID: 10940080
[TBL] [Abstract][Full Text] [Related]
17. Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda.
Bulaj ZJ; Phillips JD; Ajioka RS; Franklin MR; Griffen LM; Guinee DJ; Edwards CQ; Kushner JP
Blood; 2000 Mar; 95(5):1565-71. PubMed ID: 10688809
[TBL] [Abstract][Full Text] [Related]
18. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
[TBL] [Abstract][Full Text] [Related]
19. Porphyria cutanea tarda, hepatitis C, uroporphyrinogen decarboxylase and mutations of HFE gene. A case-control study.
Cribier B; Chiaverini C; Dali-Youcef N; Schmitt M; Grima M; Hirth C; Lacour JP; Chosidow O
Dermatology; 2009; 218(1):15-21. PubMed ID: 19001803
[TBL] [Abstract][Full Text] [Related]
20. Human leukocyte antigen haplotypes and HFE mutations in Spanish hereditary hemochromatosis and sporadic porphyria cutanea tarda.
Gonzalez-Hevilla M; de Salamanca RE; Morales P; Martínez-Laso J; Fontanellas A; Castro MJ; Rojo R; Moscoso J; Zamora J; Serrano-Vela JI; Arnaiz-Villena A
J Gastroenterol Hepatol; 2005 Mar; 20(3):456-62. PubMed ID: 15740492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
